Evidence map›Paper›PMID 33598509›Full record

ArticleRegenerative therapy2021

Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche.

Tadahito Yasuda, Takatsugu Ishimoto, Hideo Baba

Abstract read
In one paragraph

Article in Regenerative therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Glioblastoma stem cell metabolism and immunity.Cancer metastasis reviews · 2024
    Review
  9. Review
  10. Review
  11. Epithelial-Mesenchymal Transition in Acute Leukemias.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tadahito YasudaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Takatsugu IshimotoDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Hideo BabaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have revealed that cancer stem cells (CSCs) undergo metabolic alterations that differentiate them from non-CSCs. Inhibition of specific metabolic pathways in CSCs has been conducted to eliminate the CSC population in many types of cancer. However, there is conflicting evidence about whether CSCs depend on glycolysis or mitochondrial oxidative phosphorylation (OXPHOS) to maintain their stem cell properties. This review summarizes the latest knowledge regarding CSC-specific metabolic alterations and offers recent evidence that the surrounding microenvironments may play an important role in the maintenance of CSC properties.

Indexed as

ALDH, aldehyde dehydrogenaseATP, adenosine triphosphateCD44v, CD44 variant isoformCSCsCSCs, cancer stem cellsEMT, epithelial–mesenchymal transitionEVs, extracellular vesiclesFAO, fatty acid oxidationFBP1, fructose-1,6-biphosphatase 1GLUT1, glucose transporter 1GlycolysisGP6, glucose-6-phosphateHCC, hepatocellular carcinomaHIF1a, hypoxia inducible factor 1aIMP2, insulin-like growth factor 2IncRNAs, long noncoding RNAsLSCs, leukemia stem cellsMitochondrial OXPHOSmTORC1, mammalian target of rapamycin complex 1NRF2, nuclear factor erythroid 2–related factor 2OXPHOS, oxidative phosphorylationPDK1, pyruvate dehydrogenase kinase 1PPP, pentose phosphate pathwayROSROS, reactive oxygen speciesSOD2, superoxide dismutase 2Stromal nicheTCA, tricarboxylic acidTICs, tumor initiating stem-like cells

Identifiers

PMID33598509
PMCPMC7851492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.